SPICSouthern Petrochemical Industries Corporation Ltd.
Southern Petrochemical Industries Corporation appoints Dr D Karthikeyan as nominee director
- Management change
- Fertilisers
Reviewed byRachit TripathiBlacklitt Research
Southern Petrochemical Industries Corporation (NSE: SPIC) has appointed Dr D Karthikeyan as a Non-Executive Nominee Director, effective 4 Nov 2026, it said in a filing on 04 Nov 2026. The appointment is subject to shareholder approval, and he joins as an additional director.
The appointment and his background
The board made the appointment at its meeting on 4 Nov 2026. Dr D Karthikeyan (DIN: 02259481) is appointed as an Additional Director in the category of Non-Executive Nominee Director, with effect from 4 Nov 2026. The company gives the reason for the change as appointment.
He is a 1997 batch IAS officer and is currently Principal Secretary and Chairman and Managing Director of Tamilnadu Industrial Development Corporation Limited. Earlier he was Commissioner of the Coimbatore Corporation, where he received 2 National Awards for e-governance, and Collector of Erode, where he was named Best Collector for rural development and welfare of the differently abled. He also served as Commissioner of Greater Chennai Corporation for 3 tenures.
He has declared that he is not disqualified or debarred from being appointed as a director by any SEBI order or other authority. The company reports no disclosed relationship between him and the other directors.
A nominee seat, pending shareholder approval
The filing describes him as a nominee director but its text does not give the shareholder meeting at which approval will be sought, the term of the appointment, or any remuneration. It also does not say which shareholder or authority he is nominated by.
What the appointment means for Southern Petrochemical Industries Corporation's shareholders
The change adds one non-executive nominee to the board, and the appointment takes effect only once shareholders approve it. The filing does not say when that approval meeting will be held, how long the appointment runs, what he will be paid, or whom he represents. The next dated step is the shareholder vote, for which no date is given.
The company's Q1 FY27 consolidated total income was ₹850.29 crore, up 6.5% YoY, and net profit was ₹60.18 crore, down 9.8% YoY. The filing does not link the appointment to those results.
At a glance
| Item | Detail |
|---|---|
| Director | Dr D Karthikeyan (DIN: 02259481) |
| Category | Non-Executive Nominee Director, Additional Director |
| Effective date | 4 Nov 2026, subject to shareholder approval |
| Board meeting | 4 Nov 2026 |
Filed with NSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
